Brand Name | Status | Last Update |
---|---|---|
perseris | New Drug Application | 2025-01-28 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Recurrence | D012008 | — | — | 3 | 2 | — | — | — | 4 |
Lymphoma | D008223 | — | C85.9 | 3 | 2 | — | — | — | 4 |
T-cell lymphoma peripheral | D016411 | — | — | 1 | 3 | — | — | — | 3 |
T-cell lymphoma | D016399 | — | — | 2 | 2 | — | — | — | 3 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 2 | — | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | 1 | — | — | — | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | — | 1 | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sezary syndrome | D012751 | — | C84.1 | 2 | — | — | — | — | 2 |
Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
T-cell lymphoma cutaneous | D016410 | — | C84.A | 2 | — | — | — | — | 2 |
Mucositis | D052016 | EFO_1001898 | — | 2 | — | — | — | — | 2 |
Primary cutaneous anaplastic large cell lymphoma | D054446 | — | C86.6 | 1 | — | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
Drug common name | Polyglycolic acid |
INN | polyglycolic acid |
Description | Polyglycolide or poly(glycolic acid) (PGA), also spelled as polyglycolic acid, is a biodegradable, thermoplastic polymer and the simplest linear, aliphatic polyester. It can be prepared starting from glycolic acid by means of polycondensation or ring-opening polymerization. PGA has been known since 1954 as a tough fiber-forming polymer. Owing to its hydrolytic instability, however, its use has initially been limited. Currently polyglycolide and its copolymers (poly(lactic-co-glycolic acid) with lactic acid, poly(glycolide-co-caprolactone) with ε-caprolactone and poly (glycolide-co-trimethylene carbonate) with trimethylene carbonate) are widely used as a material for the synthesis of absorbable sutures and are being evaluated in the biomedical field.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 26009-03-0 |
RxCUI | — |
ChEMBL ID | CHEMBL2107965 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | H1IL6F7KB8 (ChemIDplus, GSRS) |